Authors' Reply.

Clarke, Candice L; Prendecki, Maria; McAdoo, Stephen P; Willicombe, Michelle

Authors' Reply.

Clarke, Candice L; Prendecki, Maria; McAdoo, Stephen P; Willicombe, Michelle.

Clarke CL; Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, United Kingdom candice.clarke@imperial.ac.uk.
Prendecki M; Imperial College Renal and Transplant Centre, Imperial College Healthcare National Health Service Trust, Hammersmith Hospital, London, United Kingdom.
McAdoo SP; Department of Immunology and Inflammation, Centre for Inflammatory Disease, Imperial College London, London, United Kingdom.
Willicombe M; Imperial College Renal and Transplant Centre, Imperial College Healthcare National Health Service Trust, Hammersmith Hospital, London, United Kingdom.

J Am Soc Nephrol ; 31(12): 2967-2968, 2020 12.

Article in English | MEDLINE | ID: covidwho-819958

Subject(s)

COVID-19; Humans; Mass Screening; Pandemics; Prevalence; Renal Dialysis; SARS-CoV-2

Keywords

COVID-19; Seroprevalence

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: J Am Soc Nephrol Journal subject: Nephrology Year: 2020 Document Type: Article Affiliation country: Asn.2020091276

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google